This bid is closed — responses were due August 27, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This bid is a Notice of Intent to Sole Source for a Vela Sentosa SQ Next Generation Sequencing (NGS) system, specifically for FDA Approved HIV-1 Genotype Testing.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Vela Sentosa SQ Next Generation Sequencing (NGS) System
1
each
$250,000.00
$250,000.00
Medical
Estimated Bid Value
$250,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds contracting-officer contacts and AI response outlines.